[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 30, Issue 4 ( winter 2020) ::
MEDICAL SCIENCES 2020, 30(4): 341-351 Back to browse issues page
Beta thalassemia gene therapy using lentiviral vectors
Mohammad Ali Khosravi1 , Maryam Abbasalipour1 , Sirous Zeinali2 , Morteza Karimipoor 3
1- PhD of Medical Biotechnology, Department of Molecular Medicine, Pasteur Institute of Tehran, Tehran, Iran
2- Department of Molecular Medicine, Pasteur Institute of Iran, Tehran, Tehran, Iran
3- Department of Molecular Medicine, Pasteur Institute of Iran, Tehran, Tehran, Iran , mortezakarimi@yahoo.com
Abstract:   (474 Views)
Recent years, allogeneic bone marrow transplantation (BMT) has proved to be the successful cure for patients with thalassemia major, however this is restricted due to limited matched-related donor. Its complications include chronic graft-versus-host disease in 5-8% of patients. So, a molecular approach, such as gene therapy for direct normal beta globin gene transmission, seems quite promising to cure thalassemia. The goal of beta thalassemia gene therapy is to restore normal RBC production capacity in patients by suitable vector and correct inherited anemia. Virus therapy has recently been recognized as a promising new therapeutic approach in medical research. In this regard, the use of viruses as non-replicating gene therapy vectors or as replication viruses (oncolytic viruses) has provided attractive opportunities for viral therapy applications. Currently viral vectors have been used in nearly 70% of the clinical trials. In recent years, many researchers have designed erythroid-specific lentiviral vectors carrying the beta-globin gene that have obtained significant results. Their findings are presented in this study.
Keywords: Beta- thalassemia, Gene therapy, Lentiviral vector.
Full-Text [PDF 2463 kb]   (263 Downloads)    
Semi-pilot: Review | Subject: Genetic
Received: 2019/09/1 | Accepted: 2020/01/27 | Published: 2020/12/20
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA



XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Khosravi M A, Abbasalipour M, Zeinali S, Karimipoor M. Beta thalassemia gene therapy using lentiviral vectors. MEDICAL SCIENCES. 2020; 30 (4) :341-351
URL: http://tmuj.iautmu.ac.ir/article-1-1837-en.html


Volume 30, Issue 4 ( winter 2020) Back to browse issues page
فصلنامه علوم پزشکی دانشگاه آزاد اسلامی واحد پزشکی تهران Medical Science Journal of Islamic Azad Univesity - Tehran Medical Branch
Persian site map - English site map - Created in 0.05 seconds with 30 queries by YEKTAWEB 4282